CoChat

The Pomegranate: Nature's Power Fruit?

Longtin, R. · 2003 · JNCI Journal of the National Cancer Institute
Cited by 149

The DOI matches its Crossref record.

Abstract

Mention pomegranates to Ephraim Lansky, M.D., and he will gladly offer you his opinion, though he probably won’t mention whether he likes to eat the seed-filled fruit. What interests Lansky about pomegranates is, in his words, the “extraordinary” medicinal properties of the tree itself, an idea that dates to Biblical times and which, he says, has been oddly overlooked by Western medicine. So bullish is Lansky on the health-promoting properties of the pomegranate tree—fruit, leaves, bark, and all—that he launched a start-up company 3 years ago in Israel to move his idea into the marketplace. Already, the company has created a fermented, antioxidant-rich juice supplement that it promotes for better cardiovascular health, and Lansky said that other products and markets await. Among them is a special blend of pomegranate juice, seed, and peel that, according to published results, potently and reproducibly kills prostate and breast cancer cells in culture. Lansky said he hopes to move his extract into clinical trials as quickly as possible. If the initial data establish the efficacy of the product, he envisions additional human trials and ultimately regulatory approval. Although Lansky’s drug development strategy seems to cover most of the scientific bases, it still leaves wide open one fundamental question: In a world of reductionist science, where researchers study single compounds as new therapeutic agents, is it possible to rationally develop a botanical drug that consists of hundreds of distinct molecules? According to several experts, though the idea remains a huge challenge scientifically, it may not be as farfetched today as it once seemed. Reports of the pomegranate’s medicinal qualities have echoed throughout the millennia. In addition to Biblical references, the Romans mention the tree’s unique healing powers, and several Middle Eastern, Asian, and South American peoples continue to chew small bits of its bark, petals, and peel to treat ailments ranging from dysentery to diseases of the mouth and gums. The echoes have been slow to interest Western scientists, however. Some say the indifference may owe to geography. Because the pomegranate is native to the Middle East and a rare item in Western diets, the tree may have simply fallen through the cultural cracks. In fact, a Medline search reveals that just 38 papers were published on pomegranates from 1975 to 1999, many of questionable quality. By the late 1990s, the West slowly began to take more notice, thanks in part to a wave of interest in the pomegranate among Israeli scientists. Lansky became interested in the fruit during the early 1990s and eventually founded his company, Rimonest, a linguistic marriage of the Hebrew word “rimon,” or pomegranate, and the English superlative “-est.” Then, in 2000, Michael Aviram, D.Sc., and colleagues at the Rambaum Medical Center in Haifa reported that people who supplemented their diets with pomegranate juice, which is high in antioxidants, seemed to improve some key indicators of cardiovascular health. For those scientists who have examined the pomegranate, most say they are impressed. “In general, I would say the pomegranate is ‘extraordinary’ and offers the opportunity to find new substances with health promoting properties,” said Ivo Feussner, Ph.D., a scientist at University of Goettingen’s Albrecht von Haller Institute for Plant Sciences in Germany, who has studied the chemical composition of pomegranate oil. “Therefore, this fruit needs to be studied more intensely.” What particularly intrigues these scientists is the unique biochemistry of the pomegranate tree. In addition to the high levels of antioxidant-rich tannins and flavonoids in the juice and peel, researchers crush and dry the seeds to produce a unique oil, about 80% of which is a very rare 18-carbon fatty acid, or punicic acid. Also present in the oil is the isoflavone genistein, the phytoestrogen coumestrol, and the sex steroid estrone. In fact, the pomegranate is one of the only plants in nature known to contain estrone. “All of this chemical peculiarity may be related to the fruit’s botanical isolation,” noted Lansky. “The pomegranate sits alone in its own botanical family, accompanied by its rare genetic forebear, whose habitat is restricted to the Yemeni island of Socotra.” Lansky, in particular, has championed the hypothesis that the plant’s chemical peculiarity might be effective in treating cancer, an idea that, he said, was supported in his initial in vitro work. Rather than take the standard reductionist step of sifting through his fruity mixture to isolate one ingredient that inhibits the tumor cells, Lansky went in the other intellectual direction. Trained as a homeopathist, Lansky argued that the whole worked better than the one active ingredient, a concept known as “herbal synergy.” Herbalists argue that this chemical synergy can be transferred in its entirety to people. Take a complex botanical therapy, they say, and it will hav

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/95.5.346

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 149

Metadata

Authors
Longtin, R.
Venue
JNCI Journal of the National Cancer Institute
Published
2003-03-05
Volume
95
Issue
5
Pages
346-348
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2097213638
Cited by
149
References
0
FWCI
4.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Pomegranate: Nature's Power Fruit? https://app.cochat.ai/papers/10.1093/jnci/95.5.346
The paper
Longtin, R. (2003). The Pomegranate: Nature's Power Fruit? JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/95.5.346

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.